10/1/2012 7:24:06 AM
Aragon Pharmaceuticals Inc. has raised $50 million in equity funding, according to a filing Tuesday with the Securities and Exchange Commission. The date of first sale was Sept. 14, according to the filing. The investment was the second reported this year by Aragon Pharma. On Aug. 2, the privately held company reported in an amended SEC filing that it had raised $37.8 million in equity, with the first sale taking place Feb. 24. Aragon Pharma is developing small-molecule drugs to treat hormone-driven cancers.
comments powered by